Tomorrow’s Cure: How DNA guides cancer detection

This content is courtesy of Mayo Clinic, the No. 1 hospital in the world according to Newsweek. Minnesota Oncology is a member of the Mayo Clinic Care Network. This relationship provides us with access to information, knowledge and expertise from Mayo Clinic..

What if you knew you'd get sick before you ever felt symptoms? If it was a cold, that information is useful. In the case of cancer, it is lifesaving. This week's podcast episode of Tomorrow's Cure explores how DNA could be used to detect blood cancers before they ever develop.

Episode experts include Dr. Mrinal Patnaik, a hematologist, internist and oncologist at Mayo Clinic; and Dr. Kelly Bolton, an oncologist at Washington University in St. Louis.

"We're developing tests where we can actually detect the early first step in the multistep progression to cancer," Dr. Bolton says. "That's an area where we might be able to intervene on someone's genetic changes that haven't quite led to cancer, but that are very high risk of becoming a cancer."

"When we detect clonal hematopoiesis, we want to nip it in the bud and prevent those high-risk patients from developing blood cancer because they are often lethal, difficult to treat. So the earlier we can effectively and safely intervene, the better for the patients,” says Dr. Patnaik.

DNA.png

WATCH THE VIDEO

Share

Categories

Tags

Recent Posts

#
November 18, 2025

Nonsmokers Still at Risk for Lung Cancer. In the United States, about 10% to 20% of lung cancer diagnoses happen in people who have never smoked or have smoked fewer than 100 cigarettes in their lifetime.

#
November 11, 2025

Biomarkers are proteins, hormones, or pieces of DNA that can be released by cancer cells or by your body in response to cancer.

#
September 17, 2025

Is Frequent Urination a Sign of Prostate Cancer? Frequent urination can be linked to several prostate conditions that place pressure on the urinary system.